Published in Clin Res Cardiol on December 22, 2006
Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults. Clin Res Cardiol (2008) 1.13
Hypoxia increases placenta growth factor expression in human myocardium and cultured neonatal rat cardiomyocytes. J Heart Lung Transplant (2009) 0.91
Heart-kidney biomarkers in patients undergoing cardiac stress testing. Int J Nephrol (2010) 0.86
Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia. Int J Clin Oncol (2012) 0.85
Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy. Arch Med Sci (2013) 0.81
Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement. Clin Res Cardiol (2010) 0.79
Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia. Cardiovasc J Afr (2011) 0.79
Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease. Clin Res Cardiol (2007) 0.78
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation (1994) 3.63
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med (2005) 3.35
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 2.71
Increased cardiac BNP expression associated with myocardial ischemia. FASEB J (2003) 1.78
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol (2004) 1.70
Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation (2003) 1.68
Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation (2002) 1.62
N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J (2004) 1.57
Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol (2003) 1.42
Prognostic value of placental growth factor in patients with acute chest pain. JAMA (2004) 1.40
Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem (2002) 1.33
Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) (1995) 1.23
Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc Pathol (2003) 1.22
Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol (2004) 1.19
Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J (1984) 1.03
B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease. Am J Cardiol (2005) 0.99
Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem (2002) 0.98
High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem (2004) 0.96
Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem (2004) 0.94
Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J (2002) 0.93
Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem (2004) 0.93
Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail (2004) 0.89
Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men. Am Heart J (2001) 0.88
Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem (2003) 0.87
Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma? Eur J Clin Invest (1987) 0.84
Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNP. Clin Lab (2005) 0.82
Atrial pacing stimulates secretion of atrial natriuretic polypeptide without elevation of atrial pressure in awake dogs with experimental complete atrioventricular block. Circ Res (1990) 0.79
Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol (2004) 0.75
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58
It's time for a change to a troponin standard. Circulation (2000) 2.69
Strengthening of horizontal cortical connections following skill learning. Nat Neurosci (1998) 2.66
Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet (1997) 2.54
Justification of the 4-mmol/l lactate threshold. Int J Sports Med (1985) 2.15
Troponin elevation in coronary vs. non-coronary disease. Eur Heart J (2010) 1.93
Myocardial ischemia in generalized coronary artery-left ventricular microfistulae. Int J Cardiol (1998) 1.88
Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. J Clin Invest (1997) 1.67
S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem (1991) 1.66
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Effectiveness of end-tidal carbon dioxide tension for monitoring thrombolytic therapy in acute pulmonary embolism. Crit Care Med (2000) 1.61
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia (2004) 1.56
Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology (2001) 1.54
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
Personalized messages invite more mammography. JAMA (1994) 1.43
Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation (2000) 1.43
Refractory oedema in congestive heart failure: a contributory role of loop diuretics? J Intern Med (1995) 1.40
Federal ruling reins in liberal HIV testing law, consensus still lacking on controversial issue. JAMA (1993) 1.39
New program targets death investigator training. JAMA (1996) 1.38
T lymphocyte subset values among healthy Cameroonians. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.35
The demonstration of subtype (D or Y)-specific determinants on the surface of the presumed hepatitis B virus. J Immunol (1977) 1.29
Interferon production in patients infected with HIV-1. J Infect Dis (1989) 1.23
Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis (1996) 1.22
Quantal analysis of paired-pulse facilitation in guinea pig hippocampal slices. Neurosci Lett (1987) 1.20
Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol (1996) 1.19
Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients. Am J Kidney Dis (1998) 1.17
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther (2000) 1.17
Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol (1990) 1.14
Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology (1988) 1.14
Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol (2000) 1.13
Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay. Clin Exp Immunol (1980) 1.12
High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis. Am J Kidney Dis (1998) 1.12
Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology (1997) 1.11
Bortezomib retreatment in relapsed multiple myeloma - results from a retrospective multicentre survey in Germany and Switzerland. Oncology (2011) 1.09
The maize tha4 gene functions in sec-independent protein transport in chloroplasts and is related to hcf106, tatA, and tatB. J Cell Biol (1999) 1.09
Radial artery thrombosis following transradial coronary angiography: incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins. Clin Res Cardiol (2010) 1.08
IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology (2009) 1.08
International group seeks to dispel incontinence "taboo". JAMA (1998) 1.07
Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology (1997) 1.05
Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine (1989) 1.05
An optimized AV delay algorithm for patients with intermittent atrioventricular conduction. Pacing Clin Electrophysiol (1998) 1.05
sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. J Clin Invest (1987) 1.04
T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol (1990) 1.03
Rotational and translational water diffusion in the hemoglobin hydration shell: dielectric and proton nuclear relaxation measurements. Biophys J (1993) 1.02
Development of monoclonal neutralizing antibodies against bovine viral diarrhea virus after pretreatment of mice with normal bovine cells and cyclophosphamide. J Virol Methods (1989) 1.02
Intracoronary thrombolysis in acute myocardial infarction: duration of ischemia as a major determinant of late results after recanalization. Am J Cardiol (1982) 1.02
HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med (2011) 1.01
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol (1999) 1.01
Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. Gastroenterology (1990) 1.01
The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol (2009) 1.01
Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol (2012) 1.00
Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest (2007) 0.99
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study. Diabet Med (2012) 0.99
Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia. J Clin Microbiol (2006) 0.99
HIV/AIDS in the Caribbean: big problems among small islands. JAMA (2001) 0.98
Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Eur J Haematol (1996) 0.98
Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients. Am J Transplant (2009) 0.97
New group tracks hospitals' drug-resistant bugs. JAMA (1996) 0.96
Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes. Eur J Clin Invest (2009) 0.96
Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24. Circulation (2000) 0.95
In vivo uptake of immune complexes by parenchymal and nonparenchymal liver cells in mice. Gastroenterology (1981) 0.95
Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol (1988) 0.95
Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology (1989) 0.94
Acquired thromboatheromatous coarctation of the aorta: acquired coarctation of the aorta. Int J Cardiol (1999) 0.94
Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology (1990) 0.94
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial. J Intern Med (2010) 0.94
Hepatitis C virus and sexual transmission. Lancet (1989) 0.94
Comprehensive bio-imaging using myocardial perfusion reserve index during cardiac magnetic resonance imaging and high-sensitive troponin T for the prediction of outcomes in heart transplant recipients. Am J Transplant (2014) 0.94
Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J Virol (1990) 0.93
Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest (1995) 0.92
Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience (2008) 0.92
The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases. (Studies on HBsAg-positive and -negative patients). Klin Wochenschr (1975) 0.91
Is infective blood donation missed without screening for antibody to hepatitis B core antigen and/or hepatitis B virus DNA? Vox Sang (2001) 0.91
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL. Bone Marrow Transplant (2002) 0.91
Communication gaps hinder full recovery from depression. JAMA (2001) 0.90
Natural killer cell activity as a prognostic parameter in the progression to AIDS. J Infect Dis (1988) 0.90
Myocardial hypertrophy in rats with renal insufficiency. Kidney Int (1985) 0.90
e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers. Scand J Gastroenterol (1977) 0.89
Pyruvate attenuation of hypoxia damage in isolated working guinea-pig heart. J Mol Cell Cardiol (1986) 0.89
Is hepatitis G virus transmitted sexually? JAMA (1997) 0.89
Intracoronary thrombolysis in acute myocardial infarction: correlations among serum enzyme, scintigraphic and hemodynamic findings. Am J Cardiol (1982) 0.89
Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens. Hepatology (1991) 0.88
Molecular dynamics of the alpha-helical epitope of a novel synthetic lipopeptide foot-and-mouth disease virus vaccine. Biopolymers (1989) 0.88
Dog bites recognized as public health problem. JAMA (1997) 0.88
Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents. Neuropharmacology (2008) 0.87
Multicenter evaluation of the novel ABN Western blot (immunoblot) system in comparison with an enzyme-linked immunosorbent assay and a different Western blot. J Clin Microbiol (1992) 0.87
Evaluation of the automated 'Enzymen-Test Anti HIV-1 + 2' and 'Enzymen-Test Anti HIV-1/2 selective' for the combined detection and differentiation of anti-HIV-1 and anti-HIV-2 antibodies. J Virol Methods (1993) 0.87
N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders. Z Kardiol (2005) 0.86
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis (1999) 0.86
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer. J Cancer Surviv (2007) 0.86